Top Abstract Purchase Preview Related
Home
>
Node
>
Subnode

The use of cyclosporine in dermatology

Dehesa, L.; Abuchar, A.; Nuno-Gonzalez, A.; Vitiello, M.; Kerdel, F.A.

Journal of Drugs in Dermatology Jdd 11(8): 979-987

2012

ISSN/ISBN: 1545-9616
PMID: 22859244
Document Number: 15651
Cyclosporine is an immunosuppressive drug that acts selectively on T-cells by inhibiting calcineurin phosphorylase. It has been used in dermatology since its approval for US Food and Drug Administration in 1997 for the use in psoriasis. While indicated only for the treatment of moderate to severe psoriasis, cyclosporine has also been used as an off-label drug for the treatment of various inflammatory skin conditions, including atopic dermatitis, blistering disorders, and connective tissue diseases. In this article, we review the use of cyclosporine in dermatology.

Document emailed within 1 workday
Secure & encrypted payments

The use of cyclosporine in dermatology

Eigler, F.W. 1992: Cyclosporine in dermatology Deutsche Medizinische Wochenschrift 117(13): 519
Behnam, S.M.; Behnam, S.E.; Koo, J.Y. 2005: Review of cyclosporine immunosuppressive safety data in dermatology patients after two decades of use Journal of drugs in dermatology: JDD 4(2): 189-194
Parish, L.C. 1986: Dermatology and venereology in Italy 100 years ago. Relations with American and German dermatology and venereology. I: Dermatology Giornale Italiano di Dermatologia e Venereologia: Organo Ufficiale Societa Italiana di Dermatologia e Sifilografia 121(4): 243-246
Henning, J.S.; Firoz, B.F. 2010: Combat dermatology: the prevalence of skin disease in a deployed dermatology clinic in Iraq Journal of Drugs in Dermatology: Jdd 9(3): 210-214
Abedini, R.; Matinfar, A.; Sasani, P.; Salehi, A.; Daneshpazhooh, M. 2017: Evaluation of Patients Visiting the Dermatology Emergency Unit of a University Dermatology Hospital in Tehran, Iran Acta Medica Iranica 55(11): 705-711
Morozumi, K.; Thiel, G.; Albert, F.W.; Banfi, G.; Gudat, F.; Mihatsch, M.J. 1992: Studies on morphological outcome of cyclosporine-associated arteriolopathy after discontinuation of cyclosporine in renal allografts Clinical Nephrology 38(1): 1-8
Dieperink, H.; Kemp, E.; Leyssac, P.P.; Starklint, H.; Wanscher, M.; Nielsen, J.; Jørgensen, K.A.; Faber, V.; Flachs, H. 1986: Ketoconazole and cyclosporine A: combined effects on rat renal function and on serum and tissue cyclosporine a concentration Clinical Nephrology 25(Suppl 1): S137-S143
Lorber, M.I.; Flechner, S.M.; Van Buren, C.T.; Kerman, R.H.; Kahan, B.D. 1985: Cyclosporine, azathioprine, and prednisone as treatment for cyclosporine-induced nephrotoxicity in renal transplant recipients Transplantation Proceedings 17(4 Suppl 1: 282-285
Anderson, J.E.; Morris, R.E.; Blaschke, T.F. 1987: Pharmacodynamics of cyclosporine-ketoconazole interaction in mice. Combined therapy potentiates cyclosporine immunosuppression and toxicity Transplantation 43(4): 529-533
Diliz, H.S.; Olivera, M.A.; Kershenobich, D.; Mercado, M.A.; Orozco, H. 1996: Change of conventional cyclosporine to neoral cyclosporine formulation in long-term liver transplant recipients Transplantation Proceedings 28(6): 3348-3350
Mrowietz, U.; Christophers, E. 1988: Effects of cyclosporine a treatment on psoriasis. I: Influence of low-dose cyclosporine on human monocyte function in vitro Transplantation Proceedings 20(3 Suppl 4: 53-57
Jacobs, T.W.; Katz, I.A.; Joffe, I.I.; Stein, B.; Takizawa, M.; Epstein, S. 1991: The effect of FK 506, cyclosporine A, and cyclosporine G on serum 1,25-dihydroxyvitamin D levels Transplantation Proceedings 23(6): 3188-3189
Sandrini, S.; Maiorca, R.; Scolari, F.; Cancarini, G.; Setti, G.; Gaggia, P.; Cristinelli, L.; Zubani, R.; Bonardelli, S.; Maffeis, R.; Portolani, N.; Nodari, F.; Giulini, S.M. 2000: A prospective randomized trial on azathioprine addition to cyclosporine versus cyclosporine monotherapy at steroid withdrawal, 6 months after renal transplantation Transplantation 69(9): 1861-1867
Sukhavasharin, N.; Praditpornsilpa, K.; Avihingsanon, Y.; Kuoatawintu, P.; O-Charoen, R.; Kansanabuch, T.; Tungsanga, K.; Eiam-Ong, S. 2006: Study of cyclosporine level at 2 hours after administration in preoperative kidney transplant recipients for prediction of postoperative optimal cyclosporine dose Journal of the Medical Association of Thailand 89(Suppl 2): S15-S20
Salomon, D.; Brunson, M.; Vansickler, J.; Pfaff, W.; Howard, R.; Peterson, J.; Curry, T.; Thompson, R.; Squiers, E. 1991: A retrospective analysis of late renal graft function: correlation with mean cyclosporine levels and lack of evidence for chronic cyclosporine toxicity Transplantation Proceedings 23(1 Pt 2): 1018-1019
Chen, S.S. 1988: Cyclosporine a acts as a potent co-stimulator in up-regulation of IgE antibody synthesis and expression of Fc receptor for IgE--a unifying hypothesis of the cellular mechanisms of cyclosporine a Transplantation Proceedings 20(2 Suppl 2: 92-102
Przepiorka, D.; Shapiro, S.; Schwinghammer, T.L.; Bloom, E.J.; Rosenfeld, C.S.; Shadduck, R.K.; Venkataramanan, R. 1991: Cyclosporine and methylprednisolone after allogeneic marrow transplantation: association between low cyclosporine concentration and risk of acute graft-versus-host disease Bone Marrow Transplantation 7(6): 461-465
Rooth, P.; Dawidson, I.; Clothier, N.; Diller, K. 1988: In vivo fluorescence microscopy of kidney subcapsular blood flow in mice. Effects of cyclosporine, (NVA2)-cyclosporine, and isradipine, a new calcium antagonist Transplantation 46(4): 566-569
Reissi, D.; Bardideh, A.; Samadzadeh, B.; Razi, A. 1995: Retrospective study of cyclosporine-prednisolone versus cyclosporine-azathioprine-prednisolone immunosuppression in living donor kidney transplantation Transplantation Proceedings 27(5): 2685-2686
Mottram, P.L.; Mirisklavos, A.; Clunie, G.J. 1985: Cyclosporine and murine responses to alloantigens: effects of cyclosporine and donor-specific transfusions on delayed hypersensitivity reactions and murine skin allografts Transplantation Proceedings 17(2): 1646-1649